Sun Pharma

Rediff.com » News » Sun Pharma

News for Sun Pharma

News
Business
Movies

Phase 3 clinical trial of Oxford vaccine begins in Pune

The Phase-III human clinical trial of the COVID-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at the state-run......

Phase 3 trial of Oxford vaccine to begin in Pune from next week

The Phase 3 human clinical trial of the COVID-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

Opposition seeks compensation for migrants who died during lockdown

Opposition parties in Rajya Sabha on Wednesday questioned the Modi government's claim that the lockdown helped prevent over 29 lakh COVID-19 cases and thousands of deaths, and said it should have......

Serum Institute gets nod to resume vaccine trial in India

Drugs Controller General of India Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while......

Sensex tumbles 300 pts; Nifty ends below 11,200

Maruti was the top loser in the Sensex pack, shedding around 3 per cent, followed by L&T, IndusInd Bank, Axis Bank, ONGC, Reliance Industries, Asian Paints and HDFC. On the other hand, HCL Tech,......

Covid-19 could be the boost Indian pharma cos need

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and......

Sensex erases gains; drops 134 points at close

HDFC Bank was the top loser in the Sensex pack, shedding over 2 per cent, followed by Kotak Bank, Bajaj Finserv, Maruti, Titan, SBI, HUL, HDFC and Tata Steel. On the other hand, Bharti Airtel, M&M,......

Sensex tanks 323 pts on weak global cues; Nifty below 11,550

Bajaj Finserv was the top laggard in the Sensex pack, shedding over 2 per cent, followed by PowerGrid, L&T, ICICI Bank, Bajaj Finance, TCS and Sun Pharma. On the other hand, HCL Tech, Infosys and......

'2 years is fair time for companies to come out of pain'

'The economy is expected to bounce back and things are expected to recover faster than what we previously thought.' Illustration: Uttam Ghosh/Rediff.com The two-year period for the debt......

Aarya review

'What really works is the core story, the characters who come together, the twists and turns, and, above all, Sushmita Sen,' notes Joginder Tuteja. IMAGE: Sushmita Sen plays Aarya Sareen in Ram......

Web results for Sun Pharma

GV Prasad

In the next 3-5 year there will be significant growth in our India business, our active ingredients and the services business, says GV Prasad,... ...

https://economictimes.indiatimes.com/markets/expert-view/like-it-sector-in-the-past-everythings-coming-together-for-pharma-now-gv-prasad/articleshow/78253369.cms

Sensex, Nifty Off Day's Lows; IT, Pharma Shares Outperform

The S&P BSE Sensex and NSE Nifty 50 indexes continue to trade on a weak note but came off intraday low levels in noon deals as information... ...

https://www.ndtv.com/business/sensex-nifty-live-blog-share-market-live-updates-sensex-nifty-off-days-lows-it-pharma-shares-outperform-2299230

Multi cap category topper has 53% in small cap stocks

You might have heard during the recent controversy on new Sebi norms on multi cap mutual funds that most multi cap schemes have ver little or nil... ...

https://economictimes.indiatimes.com/mf/analysis/this-multi-cap-fund-has-53-in-small-cap-stocks-also-topping-return-chart/articleshow/78250638.cms

Atul Suri

One clear sectoral winner globally is technology and that is going to find representation in our markets and in the kind of leadership that we will... ...

https://economictimes.indiatimes.com/markets/expert-view/decade-of-leadership-in-banking-has-come-to-an-end-and-the-baton-will-be-picked-up-by-it-pharma-or-others-atul-suri/articleshow/78250859.cms

BDR Pharma ready with Favipiravir 800 mg pills; will ease Covid-19 patients’ pill burden

The huge number of tablets to be consumed daily has been cited as one of the reasons for the drop in patient compliance with the treatment. ...

https://www.moneycontrol.com/news/business/exclusive-bdr-pharma-readyfavipiravir-800-mg-pills-will-ease-covid-19-patients\\u2019-pill-burden_14298901.html

See All